These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35740845)

  • 41. Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas.
    Gorincour G; Kokta V; Rypens F; Garel L; Powell J; Dubois J
    Pediatr Radiol; 2005 Dec; 35(12):1178-85. PubMed ID: 16078073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report.
    Przewratil P; Sitkiewicz A; Wyka K; Andrzejewska E
    Pediatr Dermatol; 2009; 26(4):399-404. PubMed ID: 19689513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifocal rapidly involuting congenital hemangioma: a link to chorangioma.
    Mulliken JB; Bischoff J; Kozakewich HP
    Am J Med Genet A; 2007 Dec; 143A(24):3038-46. PubMed ID: 17937433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas.
    Dai Y; Hou F; Buckmiller L; Fan CY; Saad A; Suen J; Richter GT
    Arch Otolaryngol Head Neck Surg; 2012 Feb; 138(2):177-82. PubMed ID: 22351865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
    Chang TC; Estes R
    J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The adipogenesis in infantile hemangioma and the expression of adipogenic-related genes.
    Yuan SM; Guo Y; Xu Y; Wang M; Chen HN; Shen WM
    Int J Clin Exp Pathol; 2017; 10(12):11596-11602. PubMed ID: 31966516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesenchymal stem cells and adipogenesis in hemangioma involution.
    Yu Y; Fuhr J; Boye E; Gyorffy S; Soker S; Atala A; Mulliken JB; Bischoff J
    Stem Cells; 2006 Jun; 24(6):1605-12. PubMed ID: 16456130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Giant rapidly involuting congenital hemangioma of the face: 15-year follow-up.
    Lopez-Gutierrez JC; Diaz M; Ros Z
    Arch Facial Plast Surg; 2005; 7(5):316-8. PubMed ID: 16172340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapidly involuting congenital hemangioma with fetal involution.
    Maguiness S; Uihlein LC; Liang MG; Kozakewich H; Mulliken JB
    Pediatr Dermatol; 2015; 32(3):321-6. PubMed ID: 25492638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.
    Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA
    Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial progenitor cells in infantile hemangioma.
    Yu Y; Flint AF; Mulliken JB; Wu JK; Bischoff J
    Blood; 2004 Feb; 103(4):1373-5. PubMed ID: 14576053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth characteristics of infantile hemangiomas: implications for management.
    Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
    Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.
    Li P; Guo Z; Gao Y; Pan W
    Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simple and easy surgical technique for infantile hemangiomas: intralesional excision and primary closure.
    Nomura T; Osaki T; Ishinagi H; Ejiri H; Terashi H
    Eplasty; 2015; 15():e3. PubMed ID: 25610518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia-Induced Cyr61/CCN1 Production in Infantile Hemangioma.
    Wu P; Xu H; Li N; Huo R; Shen B; Lin X; Ma G
    Plast Reconstr Surg; 2021 Mar; 147(3):412e-423e. PubMed ID: 33587560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
    Takahashi K; Mulliken JB; Kozakewich HP; Rogers RA; Folkman J; Ezekowitz RA
    J Clin Invest; 1994 Jun; 93(6):2357-64. PubMed ID: 7911127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression.
    Wu KQ; Muratore CS; So EY; Sun C; Dubielecka PM; Reginato AM; Liang OD
    Am J Pathol; 2017 Sep; 187(9):2102-2111. PubMed ID: 28710904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Role of urinary basic fibroblast growth factor in differentiating hemangiomas from vascular malformation].
    Zhang L; Lin XX; Qi ZL; Dong JS; Zou LJ; Dai CC; Li W; Wang W
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):186-8. PubMed ID: 16635349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The presentation and management of hemangiomas.
    Beck DO; Gosain AK
    Plast Reconstr Surg; 2009 Jun; 123(6):181e-191e. PubMed ID: 19483535
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.